IBRX - ImmunityBio Inc
IEX Last Trade
3.96
0.160 4.040%
Share volume: 2,275,939
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.80
0.16
4.21%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-09 | 2023-03-01 | 2023-05-11 | 2023-08-08 | 2023-11-09 | 2024-03-19 | 2024-05-09 | |
| Total revenue | 35.000 K | 118.000 K | 73.000 K | 360.000 K | 41.000 K | 82.000 K | 139.000 K | 40.000 K | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 35.000 K | 118.000 K | 73.000 K | 360.000 K | 41.000 K | 82.000 K | 139.000 K | 40.000 K | |
| 237.14% | -38.14% | 393.15% | -88.61% | 100.00% | 69.51% | -71.22% | |||
| Operating expenses | 79.657 M | 90.922 M | 84.292 M | 111.940 M | 85.186 M | 80.218 M | 84.642 M | 95.236 M | |
| Selling general and admin | 16.575 M | 19.310 M | 26.215 M | 32.676 M | 32.018 M | 31.816 M | 33.110 M | 41.885 M | |
| Research and development | 63.082 M | 71.612 M | 58.077 M | 79.264 M | 53.168 M | 48.402 M | 51.532 M | 53.351 M | |
| Total expenses | 83.557 M | 95.378 M | 87.846 M | 114.277 M | 89.143 M | 81.473 M | 84.642 M | 95.236 M | |
| 14.15% | -7.90% | 30.09% | -21.99% | -8.60% | 3.89% | 12.52% | |||
| Operating income | -83.522 M | -95.260 M | -87.773 M | -113.917 M | -89.102 M | -81.391 M | -84.503 M | -95.196 M | |
| Ebit | -83.522 M | -95.260 M | -87.773 M | -113.917 M | -89.102 M | -81.391 M | -84.503 M | -95.196 M | |
| Pretax income | -94.835 M | -111.161 M | -108.292 M | -116.583 M | -138.213 M | -95.642 M | -233.454 M | -134.130 M | |
| 17.22% | -2.58% | 7.66% | 18.55% | -30.80% | 144.09% | -42.55% | |||
| Income tax | 0.000 | 0.000 | 34.000 K | 0.000 | 0.000 | 0.000 | -40.000 K | 0.000 | |
| Net income basic | -94.588 M | -110.938 M | -108.215 M | -116.343 M | -137.879 M | -95.582 M | -233.392 M | -134.109 M | |
| -17.29% | 2.45% | -7.51% | -18.51% | 30.68% | -144.18% | 42.54% | |||
| Net income | -94.588 M | -110.938 M | -108.215 M | -116.343 M | -137.879 M | -95.582 M | -233.392 M | -134.109 M | |
| -17.29% | 2.45% | -7.51% | -18.51% | 30.68% | -144.18% | 42.54% |